EVOLUS, INC. Share-based Payment Arrangement, Expense
EVOLUS, INC. (EOLS) reported Share-based Payment Arrangement, Expense of $5.62 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-05
- EVOLUS, INC. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $5.62M, a 25.27% increase year-over-year.
- EVOLUS, INC. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $5.12M, a 13.70% decline year-over-year.
- EVOLUS, INC. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $5.15M, a 15.69% decline year-over-year.
- EVOLUS, INC. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $5.13M, a 1.63% decline year-over-year.
- EVOLUS, INC. share-based payment arrangement, expense for fiscal 2025 was $20.70M, a 6.72% decline from fiscal 2024.
- EVOLUS, INC. share-based payment arrangement, expense for fiscal 2024 was $22.19M, a 34.82% increase from fiscal 2023.
- EVOLUS, INC. share-based payment arrangement, expense for fiscal 2023 was $16.46M, a 51.92% increase from fiscal 2022.
- EVOLUS, INC. share-based payment arrangement, expense for fiscal 2022 was $10.83M, a 13.13% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.62M 10-Q · filed 2026-08-05 | $10.74M 10-Q · filed 2026-08-05 | $15.88M derived: sum of 3 quarters · filed 2026-08-05 | $21.02M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $5.12M 10-Q · filed 2026-05-04 | $10.26M derived: sum of 2 quarters · filed 2026-05-04 | $15.40M derived: sum of 3 quarters · filed 2026-05-04 | $19.89M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $5.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $10.28M derived: sum of 2 quarters · filed 2026-03-03 | $14.77M derived: sum of 3 quarters · filed 2026-08-05 | $20.70M 10-K · filed 2026-03-03 |
| 2025-09-30 | $5.13M 10-Q · filed 2025-11-05 | $9.62M derived: sum of 2 quarters · filed 2026-08-05 | $15.55M 10-Q · filed 2025-11-05 | $21.66M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $4.49M 10-Q · filed 2026-08-05 | $10.42M 10-Q · filed 2026-08-05 | $16.52M derived: sum of 3 quarters · filed 2026-08-05 | $21.74M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $5.93M 10-Q · filed 2026-05-04 | $12.03M derived: sum of 2 quarters · filed 2026-05-04 | $17.25M derived: sum of 3 quarters · filed 2026-05-04 | $23.04M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $6.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $11.32M derived: sum of 2 quarters · filed 2026-03-03 | $17.11M derived: sum of 3 quarters · filed 2026-03-03 | $22.19M 10-K · filed 2026-03-03 |
| 2024-09-30 | $5.22M 10-Q · filed 2025-11-05 | $11.00M derived: sum of 2 quarters · filed 2025-11-05 | $16.08M 10-Q · filed 2025-11-05 | $20.48M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | $5.78M 10-Q · filed 2025-08-05 | $10.86M 10-Q · filed 2025-08-05 | $15.26M derived: sum of 3 quarters · filed 2026-03-03 | $19.86M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | $5.08M 10-Q · filed 2025-05-07 | $9.48M derived: sum of 2 quarters · filed 2026-03-03 | $14.07M derived: sum of 3 quarters · filed 2026-03-03 | $18.24M derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | $4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $8.99M derived: sum of 2 quarters · filed 2026-03-03 | $13.16M derived: sum of 3 quarters · filed 2026-03-03 | $16.46M 10-K · filed 2026-03-03 |
| 2023-09-30 | $4.60M 10-Q · filed 2024-11-06 | $8.77M derived: sum of 2 quarters · filed 2024-11-06 | $12.06M 10-Q · filed 2024-11-06 | $14.47M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-06-30 | $4.17M 10-Q · filed 2024-07-31 | $7.46M 10-Q · filed 2024-07-31 | $9.88M derived: sum of 3 quarters · filed 2025-03-04 | $12.36M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-03-31 | $3.29M 10-Q · filed 2024-05-07 | $5.71M derived: sum of 2 quarters · filed 2025-03-04 | $8.19M derived: sum of 3 quarters · filed 2025-03-04 | $11.17M derived: sum of 4 quarters · filed 2025-03-04 |
| 2022-12-31 | $2.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $4.89M derived: sum of 2 quarters · filed 2025-03-04 | $7.87M derived: sum of 3 quarters · filed 2025-03-04 | $10.83M 10-K · filed 2025-03-04 |
| 2022-09-30 | $2.48M 10-Q · filed 2023-11-07 | $5.46M derived: sum of 2 quarters · filed 2023-11-07 | $8.42M 10-Q · filed 2023-11-07 | $11.07M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $2.98M 10-Q · filed 2023-08-02 | $5.94M 10-Q · filed 2023-08-02 | $8.59M derived: sum of 3 quarters · filed 2023-08-02 | $11.06M derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | $2.96M 10-Q · filed 2023-05-09 | $5.61M derived: sum of 2 quarters · filed 2023-05-09 | $8.08M derived: sum of 3 quarters · filed 2023-05-09 | $10.95M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $2.65M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $5.13M derived: sum of 2 quarters · filed 2023-03-08 | $7.99M derived: sum of 3 quarters · filed 2023-03-08 | $9.58M 10-K · filed 2023-03-08 |
| 2021-09-30 | $2.48M 10-Q · filed 2022-11-08 | $5.34M derived: sum of 2 quarters · filed 2022-11-08 | $6.93M 10-Q · filed 2022-11-08 | $9.56M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $2.86M 10-Q · filed 2022-08-02 | $4.45M 10-Q · filed 2022-08-02 | $7.08M derived: sum of 3 quarters · filed 2022-08-02 | $10.03M derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $1.59M 10-Q · filed 2022-05-10 | $4.22M derived: sum of 2 quarters · filed 2022-05-10 | $7.17M derived: sum of 3 quarters · filed 2022-05-10 | $9.55M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $5.58M derived: sum of 2 quarters · filed 2022-03-03 | $7.96M derived: sum of 3 quarters · filed 2022-03-03 | $10.58M 10-K · filed 2022-03-03 |
| 2020-09-30 | $2.95M 10-Q · filed 2021-11-02 | $5.33M derived: sum of 2 quarters · filed 2021-11-02 | $7.95M 10-Q · filed 2021-11-02 | $10.49M derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | $2.37M 10-Q · filed 2021-08-04 | $5.00M 10-Q · filed 2021-08-04 | $7.54M derived: sum of 3 quarters · filed 2021-08-04 | $10.06M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $2.63M 10-Q · filed 2021-05-12 | $5.17M derived: sum of 2 quarters · filed 2021-05-12 | $7.69M derived: sum of 3 quarters · filed 2021-05-12 | $10.15M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $5.06M derived: sum of 2 quarters · filed 2021-03-25 | $7.52M derived: sum of 3 quarters · filed 2021-03-25 | $9.52M 10-K · filed 2021-03-25 |
| 2019-09-30 | $2.53M 10-Q · filed 2020-10-29 | $4.98M derived: sum of 2 quarters · filed 2020-10-29 | $6.98M 10-Q · filed 2020-10-29 | $8.84M derived: sum of 4 quarters · filed 2020-10-29 |
| 2019-06-30 | $2.46M 10-Q · filed 2020-08-10 | $4.46M 10-Q · filed 2020-08-10 | $6.32M derived: sum of 3 quarters · filed 2020-08-10 | $7.80M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $2.00M 10-Q · filed 2020-05-11 | $3.86M derived: sum of 2 quarters · filed 2020-05-11 | $5.34M derived: sum of 3 quarters · filed 2020-05-11 | $7.96M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $3.34M derived: sum of 2 quarters · filed 2020-02-25 | $5.96M derived: sum of 3 quarters · filed 2020-02-25 | $6.97M 10-K · filed 2020-02-25 |
| 2018-09-30 | $1.48M 10-Q · filed 2019-11-04 | $4.11M derived: sum of 2 quarters · filed 2019-11-04 | $5.11M 10-Q · filed 2019-11-04 | $5.22M derived: sum of 4 quarters · filed 2019-11-04 |
| 2018-06-30 | $2.62M 10-Q · filed 2019-08-12 | $3.63M 10-Q · filed 2019-08-12 | $3.74M derived: sum of 3 quarters · filed 2019-08-12 | $3.97M derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | $1.01M 10-Q · filed 2019-05-01 | $1.12M derived: sum of 2 quarters · filed 2019-05-01 | $1.35M derived: sum of 3 quarters · filed 2019-05-01 | |
| 2017-12-31 | $114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-20 | $340.00K derived: sum of 2 quarters · filed 2019-03-20 | $586.00K 10-K · filed 2019-03-20 | |
| 2017-09-30 | $226.00K 10-Q · filed 2018-11-05 | $472.00K 10-Q · filed 2018-11-05 | ||
| 2017-06-30 | $246.00K 10-Q · filed 2018-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |